Sabra Health Care REIT Future Growth
Future criteria checks 3/6
Sabra Health Care REIT is forecast to grow earnings and revenue by 29.8% and 4.7% per annum respectively. EPS is expected to grow by 38.1% per annum. Return on equity is forecast to be 6.7% in 3 years.
Key information
29.8%
Earnings growth rate
38.1%
EPS growth rate
Health Care REITs earnings growth | 0% |
Revenue growth rate | 4.7% |
Future return on equity | 6.7% |
Analyst coverage | Good |
Last updated | 09 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 710 | 163 | N/A | N/A | 3 |
12/31/2025 | 693 | 151 | N/A | N/A | 7 |
12/31/2024 | 662 | 135 | N/A | N/A | 6 |
12/31/2023 | 645 | 14 | 301 | 301 | N/A |
9/30/2023 | 566 | -88 | 289 | 289 | N/A |
6/30/2023 | 542 | -123 | 315 | 315 | N/A |
3/31/2023 | 532 | -128 | 321 | 321 | N/A |
12/31/2022 | 532 | -78 | 316 | 316 | N/A |
9/30/2022 | 417 | -17 | 346 | 346 | N/A |
6/30/2022 | 569 | 43 | 344 | 344 | N/A |
3/31/2022 | 399 | -106 | 351 | 351 | N/A |
12/31/2021 | 388 | -113 | 356 | 356 | N/A |
9/30/2021 | 587 | -52 | 348 | 348 | N/A |
6/30/2021 | 444 | -26 | 339 | 339 | N/A |
3/31/2021 | 601 | 137 | 349 | 349 | N/A |
12/31/2020 | 601 | 138 | 355 | 355 | N/A |
9/30/2020 | 536 | 141 | 361 | 361 | N/A |
6/30/2020 | 539 | 128 | 349 | 349 | N/A |
3/31/2020 | 615 | 182 | 393 | 393 | N/A |
12/31/2019 | 668 | 69 | 372 | 372 | N/A |
9/30/2019 | 638 | 10 | 355 | 355 | N/A |
6/30/2019 | 639 | 22 | 341 | 341 | N/A |
3/31/2019 | 587 | 132 | 313 | 313 | N/A |
12/31/2018 | 628 | 269 | 361 | 361 | N/A |
9/30/2018 | 647 | 390 | 366 | 366 | N/A |
6/30/2018 | 609 | 367 | 293 | 293 | N/A |
3/31/2018 | 510 | 192 | 206 | 206 | N/A |
12/31/2017 | 408 | 148 | 136 | 136 | N/A |
9/30/2017 | 301 | 67 | N/A | 96 | N/A |
6/30/2017 | 251 | 78 | N/A | 137 | N/A |
3/31/2017 | 261 | 95 | N/A | 184 | N/A |
12/31/2016 | 261 | 60 | N/A | 176 | N/A |
9/30/2016 | 266 | 62 | N/A | 176 | N/A |
6/30/2016 | 264 | 55 | N/A | 164 | N/A |
3/31/2016 | 246 | 34 | N/A | 121 | N/A |
12/31/2015 | 239 | 69 | N/A | 121 | N/A |
9/30/2015 | 228 | 66 | N/A | 93 | N/A |
6/30/2015 | 212 | 65 | N/A | 108 | N/A |
3/31/2015 | 198 | 63 | N/A | 109 | N/A |
12/31/2014 | 184 | 37 | N/A | 85 | N/A |
9/30/2014 | 165 | 27 | N/A | 84 | N/A |
6/30/2014 | 154 | 22 | N/A | 68 | N/A |
3/31/2014 | 144 | 7 | N/A | 42 | N/A |
12/31/2013 | 135 | 26 | N/A | 62 | N/A |
9/30/2013 | 126 | 19 | N/A | 58 | N/A |
6/30/2013 | 119 | 15 | N/A | 55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SBC's forecast earnings growth (29.8% per year) is above the savings rate (0.6%).
Earnings vs Market: SBC's earnings (29.8% per year) are forecast to grow faster than the German market (15.1% per year).
High Growth Earnings: SBC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SBC's revenue (4.7% per year) is forecast to grow slower than the German market (5.5% per year).
High Growth Revenue: SBC's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SBC's Return on Equity is forecast to be low in 3 years time (6.7%).